Skip to main content
. 2020 Jul 6:zxaa245. doi: 10.1093/ajhp/zxaa245

Figure 2.

Figure 2.

Factors to consider in evaluation of bleeding risk in patients with venous thromboembolism. ALP indicates alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Hb, hemoglobin; NSAID, nonsteroidal anti-inflammatory drug; SBP, systolic blood pressure; TIA, transient ischemic attack; ULN, upper limit of normal.